Topline Results from RELIEF-PHN 1: A Phase 2, Double-blind, Placebo-controlled Trial of LX9211 in the Treatment of Postherpetic Neuralgia Pain

Authors
Category Primary study
ConferenceBritish Journal of Pain
Year 2023
This article has no abstract
Epistemonikos ID: 1533ae3b4faa6348d0e77c655bad43d14b75fb34
First added on: Apr 30, 2026